cysteamine has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiello, A; Alonzi, T; Capobianchi, MR; Castilletti, C; D'Eletto, M; Delogu, G; Falasca, L; Goletti, D; Ippolito, G; Najafi Fard, S; Nardacci, R; Petrone, L; Piacentini, M; Rossin, F | 1 |
| Quatroni, FD; Sampaio, I; Yamauti Costa, JN; Zucolotto, V | 1 |
| Francis, ML; Fraser-Pitt, D; Mercer, DK; O'Neil, DA; Smith, DW; Toledo-Aparicio, D | 1 |
3 other study(ies) available for cysteamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Topics: Aged; Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Cystamine; Cysteamine; Cystine Depleting Agents; Drug Repositioning; Female; Humans; Immunomodulating Agents; Male; Middle Aged; RNA, Viral; SARS-CoV-2; Vero Cells; Virus Replication | 2021 |
Electrochemical detection of Zika and Dengue infections using a single chip.
Topics: Animals; Antibodies, Viral; Biomarkers; Biosensing Techniques; COVID-19; Cysteamine; Dengue; Dengue Virus; Female; Gold; Humans; Infant, Newborn; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Viral Nonstructural Proteins; Zika Virus; Zika Virus Infection | 2022 |
Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection.
Topics: COVID-19; Cysteamine; Epithelial Cells; Humans; Immunity, Innate; Influenza, Human; SARS-CoV-2; Virus Diseases | 2023 |